Epigallocatechin gallate (EGCG) is the most effective cancer chemopreventive polyphenol in green tea

Nutrients

Volumn 4, Issue 11, 2012, Pages 1679-1691

  Du, Guang Jian ^a,b   Zhang, Zhiyu ^a,b   Wen, Xiao Dong ^a,b   Yu, Chunhao ^a,b   Calway, Tyler ^a,b   Yuan, Chun Su ^a,b   Wang, Chong Zhi ^a,b  

^a UNIVERSITY OF CHICAGO   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

Anticancer; Apoptosis; Cell cycle; EGCG; Epigallocatechin gallate; Flavonoids; Gallic acid; Human colorectal cancer; Structure activity relationship; Tea polyphenols

Indexed keywords

ANTINEOPLASTIC AGENT; CAFFEIC ACID; CATECHIN; CATECHIN GALLATE; EPICATECHIN; EPICATECHIN GALLATE; EPIGALLOCATECHIN; EPIGALLOCATECHIN GALLATE; GALLIC ACID; GALLOCATECHIN; GALLOCATECHIN GALLATE; LIPOCORTIN 5; POLYPHENOL; PROPIDIUM IODIDE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CANCER PREVENTION; CELL PROLIFERATION; CHEMOPROPHYLAXIS; COLORECTAL CANCER; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG STRUCTURE; FLOW CYTOMETRY; G1 PHASE CELL CYCLE CHECKPOINT; HUMAN; HUMAN CELL; MOLECULAR MODEL; STRUCTURE ACTIVITY RELATION; STRUCTURE ANALYSIS; TEA;

EID: 84870581169     PISSN: 20726643     EISSN: None     Source Type: Journal    
DOI: 10.3390/nu4111679     Document Type: Article

References (31)

1. Siegel, R.; Naishadham, D.; Jemal, A. Cancer statistics, 2012. CA Cancer J. Clin. 2012, 62, 10-29.
2. Wood, C.G. Multimodal approaches in the management of locally advanced and metastatic renal cell carcinoma: Combining surgery and systemic therapies to improve patient outcome. Clin. Cancer Res. 2007, 13, 697s-702s.
3. Randhawa, M.A.; Alghamdi, M.S. Anticancer activity of Nigella sativa (black seed)-A review. Am. J. Chin. Med. 2011, 39, 1075-1091.
4. Oettle, H.; Post, S.; Neuhaus, P.; Gellert, K.; Langrehr, J.; Ridwelski, K.; Schramm, H.; Fahlke, J.; Zuelke, C.; Burkart, C.; Gutberlet, K. et al. Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: A randomized controlled trial. JAMA 2007, 297, 267-277.
5. Xu, Z.; Chen, X.; Zhong, Z.; Chen, L.; Wang, Y. Ganoderma lucidum polysaccharides: Immunomodulation and potential anti-tumor activities. Am. J. Chin. Med. 2011, 39, 15-27.
6. Biagi, J.J.; Raphael, M.J.; Mackillop, W.J.; Kong, W.; King, W.D.; Booth, C.M. Association between time to initiation of adjuvant chemotherapy and survival in colorectal cancer: A systematic review and meta-analysis. JAMA 2011, 305, 2335-2342.
7. Wang, C.Z.; Calway, T.; Yuan, C.S. Herbal medicines as adjuvants for cancer therapeutics. Am. J. Chin. Med. 2012, 40, 657-669.
8. Bougnoux, P.; Hajjaji, N.; Maheo, K.; Couet, C.; Chevalier, S. Fatty acids and breast cancer: Sensitization to treatments and prevention of metastatic re-growth. Prog. Lipid Res. 2010, 49, 76-86.
9. Handbook of Antioxidants; Cadenas, E., Packer, L., Eds.; Marcel Dekker, Inc.: New York, NY, USA, 2002; p. 711.
10. Fuchs-Tarlovsky, V. Role of antioxidants in cancer therapy. Nutrition 2012, in press.
11. Lawless, M.W.; O'Byrne, K.J.; Gray, S.G. Targeting oxidative stress in cancer. Expert Opin. Ther. Targets 2010, 14, 1225-1245.
12. Wang, C.Z.; Mehendale, S.R.; Calway, T.; Yuan, C.S. Botanical flavonoids on coronary heart disease. Am. J. Chin. Med. 2011, 39, 661-671.
13. Kumar, N.; Shibata, D.; Helm, J.; Coppola, D.; Malafa, M. Green tea polyphenols in the prevention of colon cancer. Front. Biosci. 2007, 12, 2309-2315.
14. Mak, J.C. Potential role of green tea catechins in various disease therapies: Progress and promise. Clin. Exp. Pharmacol. Physiol. 2012, 39, 265-273.
15. Li, B.; Zhao, J.; Wang, C.Z.; Searle, J.; He, T.C.; Yuan, C.S.; Du, W. Ginsenoside Rh2 induces apoptosis and paraptosis-like cell death in colorectal cancer cells through activation of p53. Cancer Lett. 2011, 301, 185-192.
16. Rodriguez, M.; Du, G.J.; Wang, C.Z.; Yuan, C.S. Letter to the editor: Panaxadiol's anticancer activity is enhanced by epicatechin. Am. J. Chin. Med. 2010, 38, 1233-1235.
17. Du, G.J.; Wang, C.Z.; Qi, L.W.; Zhang, Z.Y.; Calway, T.; He, T.C.; Du, W.; Yuan, C.S. The synergistic apoptotic interaction of panaxadiol and epigallocatechin gallate in human colorectal cancer cells. Phytother. Res. 2012, doi:10.1002/ptr.4707.
18. Nakazato, T.; Ito, K.; Ikeda, Y.; Kizaki, M. Green tea component, catechin, induces apoptosis of human malignant B cells via production of reactive oxygen species. Clin. Cancer Res. 2005, 11, 6040-6049.
19. Lambert, J.D.; Elias, R.J. The antioxidant and pro-oxidant activities of green tea polyphenols: A role in cancer prevention. Arch. Biochem. Biophys. 2010, 501, 65-72.
20. Fujiki, H.; Suganuma, M. Green tea: An effective synergist with anticancer drugs for tertiary cancer prevention. Cancer Lett. 2012, 324, 119-125.
21. Chan, J.; Huang, Z.; Merrifield, M.E.; Salgado, M.T.; Stillman, M.J. Studies of metal binding reactions in metallothioneins by spectroscopic, molecular biology, and molecular modeling techniques. Coord. Chem. Rev. 2002, 233-234, 319-339.
22. Singh, B.N.; Shankar, S.; Srivastava, R.K. Green tea catechin, epigallocatechin-3-gallate (EGCG): Mechanisms, perspectives and clinical applications. Biochem. Pharmacol. 2011, 82, 1807-1821.
23. Cabrera, C.; Artacho, R.; Gimenez, R. Beneficial effects of green tea-A review. J. Am. Coll. Nutr. 2006, 25, 79-99.
24. Yanagimoto, K.; Ochi, H.; Lee, K.G.; Shibamoto, T. Antioxidative activities of volatile extracts from green tea, oolong tea, and black tea. J. Agric. Food Chem. 2003, 51, 7396-7401.
25. Henning, S.M.; Wang, P.; Heber, D. Chemopreventive effects of tea in prostate cancer: Green tea versus black tea. Mol. Nutr. Food. Res. 2011, 55, 905-920.
26. Thakur, V.S.; Gupta, K.; Gupta, S. Green tea polyphenols causes cell cycle arrest and apoptosis in prostate cancer cells by suppressing class I histone deacetylases. Carcinogenesis 2012, 33, 377-384.
27. Belguise, K.; Guo, S.; Sonenshein, G.E. Activation of FOXO3a by the green tea polyphenol epigallocatechin-3-gallate induces estrogen receptor alpha expression reversing invasive phenotype of breast cancer cells. Cancer Res. 2007, 67, 5763-5770.
28. Lu, G.; Liao, J.; Yang, G.; Reuhl, K.R.; Hao, X.; Yang, C.S. Inhibition of adenoma progression to adenocarcinoma in a 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced lung tumorigenesis model in A/J mice by tea polyphenols and caffeine. Cancer Res. 2006, 66, 11494-11501.
29. Larsen, C.A.; Bisson, W.H.; Dashwood, R.H. Tea catechins inhibit hepatocyte growth factor receptor (MET kinase) activity in human colon cancer cells: Kinetic and molecular docking studies. J. Med. Chem. 2009, 52, 6543-6545.
30. Wang, C.Z.; Luo, X.; Zhang, B.; Song, W.X.; Ni, M.; Mehendale, S.; Xie, J.T.; Aung, H.H.; He, T.C.; Yuan, C.S. Notoginseng enhances anti-cancer effect of 5-fluorouracil on human colorectal cancer cells. Cancer Chemother. Pharmacol. 2007, 60, 69-79.
31. Reed, J.C.; Pellecchia, M. Apoptosis-based therapies for hematologic malignancies. Blood 2005, 106, 408-418.